Cathinone

Cathinone
Clinical data
ATC code	none;
Legal status
Legal status	AU: S9 (Prohibited) ; BR: F2 ; CA: Schedule III ; DE: Anlage I; --> UK: Class C ; US: Schedule I ; UN: Psychotropic Schedule I ;
Pharmacokinetic data
Elimination half-life	0.7–2.3 h
Identifiers
	IUPAC name (S)-2-Amino-1-phenylpropan-1-one;
CAS Number	71031-15-7 ;
PubChem CID	62258;
DrugBank	DB01560 ;
ChemSpider	56062 ;
UNII	540EI4406J;
KEGG	C08301 ;
ChEBI	CHEBI:4110 ;
ChEMBL	CHEMBL2104047 ;
ECHA InfoCard	100.163.927
Chemical and physical data
Formula	C9H11NO
Molar mass	149.19 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(c1ccccc1)[C@@H](N)C;
	InChI InChI=1S/C9H11NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7H,10H2,1H3/t7-/m0/s1 ; Key:PUAQLLVFLMYYJJ-ZETCQYMHSA-N ;
(what is this?) (verify)

Cathinone (Cathinone /ˈkæθɪnoʊn/; mā kiò-tsò benzoylethanamine (甲酰乙醇胺) hi̍k-tsiá β-keto-amphetamine (β-酮苯丙胺); hàn-gú: 卡西酮, 苯甲醯乙胺) sī tsi̍t-tsióng teh kuàn-bo̍k (灌木) Catha edulis (卡塔葉) lāi-té huat-hiān ê monoamine alkaloid (單胺生物鹼), i-ê huà-ha̍k sìng-tsit kap ephedrine (麻黃鹼), cathine (去甲腎上腺素), methcathinone (甲卡西酮) kap kî-thann amphetamine (苯丙胺) luī-sū. Cathinone khó-lîng sī Catha edulis (卡塔葉) (mā kiò-tsò khat (阿拉伯茶)) ê hing-hùn tsok-iōng ê tsú-iàu kòng-hiàn-tsiá. Cathinone kah tsiânn-tsē kî-thann amphetamine (安非他命) bô kâng ê sóo-tsāi teh i kū-iú ê ketone (酮) kuann-lîng ki (官能基). Kî-thann kū-iú tsit-tsióng kiat-kòo ê phenethylamine (苯乙胺) pau-kuat hing-hùn-tse methcathinone (甲卡西酮), MDPV, mephedrone (甲氧麻黃酮) kap khòng ut-tsut io̍h (抗抑鬱藥) bupropion (安非他酮).

Tsù-kái

↑ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (ēng Phû-tô-gâ-gí). Diário Oficial da União 2023-07-25 chhhut-pán. goân-loē-iông tī 2023-08-27 hőng khó͘-pih. 2023-08-27 khòaⁿ--ê.
↑ Toennes SW, Harder S, Schramm M, Niess C, Kauert GF (July 2003). "Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves". British Journal of Clinical Pharmacology. 56 (1): 125–130. doi:10.1046/j.1365-2125.2003.01834.x. PMC 1884326  . PMID 12848785.

Tsham-ua̍t

Bupropion
Central nervous system
Khat
Substituted cathinone

Guā-pōo liân-kiat

[1] Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (ēng Phû-tô-gâ-gí). Diário Oficial da União 2023-07-25 chhhut-pán. goân-loē-iông tī 2023-08-27 hőng khó͘-pih. 2023-08-27 khòaⁿ--ê.

[2] Toennes SW, Harder S, Schramm M, Niess C, Kauert GF (July 2003). "Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves". British Journal of Clinical Pharmacology. 56 (1): 125–130. doi:10.1046/j.1365-2125.2003.01834.x. PMC 1884326  . PMID 12848785.

[1]

[2]

Clinical data


ATC code	none
Legal status
Legal status	AU: S9 (Prohibited) BR: F2 ^[1] CA: Schedule III DE: Anlage I --> UK: Class C US: Schedule I UN: Psychotropic Schedule I
Pharmacokinetic data
Elimination half-life	0.7–2.3 h^[2]
Identifiers
IUPAC name (S)-2-Amino-1-phenylpropan-1-one
CAS Number	71031-15-7^Y
PubChem CID	62258
DrugBank	DB01560^Y
ChemSpider	56062^Y
UNII	540EI4406J
KEGG	C08301^Y
ChEBI	CHEBI:4110^Y
ChEMBL	CHEMBL2104047^N
ECHA InfoCard	100.163.927
Chemical and physical data
Formula	C₉H₁₁NO
Molar mass	149.19 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(c1ccccc1)[C@@H](N)C
InChI InChI=1S/C9H11NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7H,10H2,1H3/t7-/m0/s1^Y Key:PUAQLLVFLMYYJJ-ZETCQYMHSA-N^Y
^NY (what is this?) (verify)